Skip to main content
Erschienen in: International Ophthalmology 6/2013

01.12.2013 | Original Paper

Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion

verfasst von: Hidetaka Noma, Katsunori Shimada, Tatsuya Mimura

Erschienen in: International Ophthalmology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

The influence of retinal ischemia on changes of visual acuity, macular sensitivity, macular thickness, and macular volume is unclear after pars plana vitrectomy (PPV) for macular edema with branch retinal vein occlusion (BRVO). Twenty-three patients (23 eyes) with BRVO and macular edema underwent PPV. Retinal ischemia was evaluated from capillary non-perfusion on fluorescein angiography, and patients were classified as ischemic or nonischemic. Microperimetry was performed with a Micro Perimeter 1. Macular thickness and volume were measured by optical coherence tomography. Mean macular thickness within the central 4°, 10°, and 20° fields decreased significantly from before to 3 and 6 months after PPV (all P < 0.001). Likewise, total macular volume within the central 4°, 10°, and 20° fields decreased significantly from before to 3 and 6 months after PPV (all P < 0.001). Best-corrected visual acuity (BCVA) improved significantly from before to 3 and 6 months after PPV (P < 0.001). Furthermore, mean macular sensitivity within the central 4°, 10°, and 20° fields increased significantly from before to 3 and 6 months after PPV (P = 0.002, P = 0.001, and P = 0.001, respectively). There were no significant differences in the trend profiles of macular thickness, macular volume, and BCVA between the ischemic and nonischemic groups. However, there was a significant difference in the trend profile of macular sensitivity within the central 4°, 10°, and 20° fields between the ischemic and nonischemic groups (P = 0.017, P = 0.010 and P = 0.025, respectively). These findings suggest PPV may be more effective for improving macular sensitivity in ischemic than nonischemic BRVO.
Literatur
1.
Zurück zum Zitat Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM (1996) Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103:551–560PubMedCrossRef Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM (1996) Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103:551–560PubMedCrossRef
2.
Zurück zum Zitat Noma H, Funatsu H, Sakata K et al (2009) Macular microcirculation and macular oedema in branch retinal vein occlusion. Br J Ophthalmol 93:630–633PubMedCrossRef Noma H, Funatsu H, Sakata K et al (2009) Macular microcirculation and macular oedema in branch retinal vein occlusion. Br J Ophthalmol 93:630–633PubMedCrossRef
3.
Zurück zum Zitat Noma H, Funatsu H, Yamasaki M et al (2005) Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140:256–261PubMed Noma H, Funatsu H, Yamasaki M et al (2005) Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140:256–261PubMed
4.
Zurück zum Zitat Noma H, Minamoto A, Funatsu H et al (2006) Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244:309–315PubMedCrossRef Noma H, Minamoto A, Funatsu H et al (2006) Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244:309–315PubMedCrossRef
5.
Zurück zum Zitat Noma H, Funatsu H, Yamasaki M et al (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22:42–48PubMedCrossRef Noma H, Funatsu H, Yamasaki M et al (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22:42–48PubMedCrossRef
6.
Zurück zum Zitat Kriechbaum K, Michels S, Prager F et al (2008) Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 92:518–522PubMedCrossRef Kriechbaum K, Michels S, Prager F et al (2008) Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 92:518–522PubMedCrossRef
7.
Zurück zum Zitat Prager F, Michels S, Kriechbaum K et al (2009) Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 93:452–456PubMedCrossRef Prager F, Michels S, Kriechbaum K et al (2009) Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 93:452–456PubMedCrossRef
8.
Zurück zum Zitat Brown DM, Campochiaro PA, Bhisitkul RB et al (2011) Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 118:1594–1602PubMedCrossRef Brown DM, Campochiaro PA, Bhisitkul RB et al (2011) Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 118:1594–1602PubMedCrossRef
9.
Zurück zum Zitat Scott IU, Ip MS, VanVeldhuisen PC et al (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol 127:1115–1128PubMedCrossRef Scott IU, Ip MS, VanVeldhuisen PC et al (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol 127:1115–1128PubMedCrossRef
10.
Zurück zum Zitat The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271–282 The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271–282
11.
Zurück zum Zitat Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E (2007) Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 27:49–54PubMedCrossRef Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E (2007) Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 27:49–54PubMedCrossRef
12.
Zurück zum Zitat Yamaike N, Kita M, Tsujikawa A, Miyamoto K, Yoshimura N (2007) Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion. Am J Ophthalmol 143:342–344PubMedCrossRef Yamaike N, Kita M, Tsujikawa A, Miyamoto K, Yoshimura N (2007) Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion. Am J Ophthalmol 143:342–344PubMedCrossRef
13.
Zurück zum Zitat Yamaike N, Tsujikawa A, Sakamoto A et al (2009) Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Retina 29:757–767PubMedCrossRef Yamaike N, Tsujikawa A, Sakamoto A et al (2009) Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Retina 29:757–767PubMedCrossRef
14.
Zurück zum Zitat Noma H, Funatsu H, Mimura T, Harino S, Shimada K (2011) Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema. Retina 31:2102–2108PubMedCrossRef Noma H, Funatsu H, Mimura T, Harino S, Shimada K (2011) Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema. Retina 31:2102–2108PubMedCrossRef
15.
Zurück zum Zitat Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ (2008) Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246:1241–1247PubMedCrossRef Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ (2008) Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246:1241–1247PubMedCrossRef
16.
Zurück zum Zitat Kirchhoff AC, Drum ML, Zhang JX et al (2008) Hypertension and hyperlipidemia management in patients treated at community health centers. J Clin Outcomes Manag 15:125–131PubMed Kirchhoff AC, Drum ML, Zhang JX et al (2008) Hypertension and hyperlipidemia management in patients treated at community health centers. J Clin Outcomes Manag 15:125–131PubMed
17.
Zurück zum Zitat Battaglia Parodi M, Saviano S, Ravalico G (1999) Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 237:1024–1027PubMedCrossRef Battaglia Parodi M, Saviano S, Ravalico G (1999) Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 237:1024–1027PubMedCrossRef
18.
Zurück zum Zitat Branch Vein Occlusion Study Group (1986) Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 104:34–41CrossRef Branch Vein Occlusion Study Group (1986) Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 104:34–41CrossRef
19.
Zurück zum Zitat Stefansson E, Novack RL, Hatchell DL (1990) Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31:284–289PubMed Stefansson E, Novack RL, Hatchell DL (1990) Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31:284–289PubMed
20.
Zurück zum Zitat Stefansson E (2006) Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 51:364–380PubMedCrossRef Stefansson E (2006) Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 51:364–380PubMedCrossRef
21.
Zurück zum Zitat Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K (2011) Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion. Clin Ophthalmol 5:223–229PubMedCrossRef Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K (2011) Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion. Clin Ophthalmol 5:223–229PubMedCrossRef
22.
Zurück zum Zitat Okunuki Y, Usui Y, Katai N et al (2011) Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion. Am J Ophthalmol 151:610–616 e1PubMed Okunuki Y, Usui Y, Katai N et al (2011) Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion. Am J Ophthalmol 151:610–616 e1PubMed
23.
Zurück zum Zitat Hogan MJ, Alvarado JA, Weddell JE (1971) Histology of the human eye: an atlas and textbook. Saunders, Philadelphia 492 Hogan MJ, Alvarado JA, Weddell JE (1971) Histology of the human eye: an atlas and textbook. Saunders, Philadelphia 492
24.
Zurück zum Zitat Noma H, Funatsu H, Mimura T, Shimada K (2012) Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. Retina 32:1844–1852PubMedCrossRef Noma H, Funatsu H, Mimura T, Shimada K (2012) Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. Retina 32:1844–1852PubMedCrossRef
25.
Zurück zum Zitat Otani T, Yamaguchi Y, Kishi S (2004) Serous macular detachment secondary to distant retinal vascular disorders. Retina 24:758–762PubMedCrossRef Otani T, Yamaguchi Y, Kishi S (2004) Serous macular detachment secondary to distant retinal vascular disorders. Retina 24:758–762PubMedCrossRef
26.
Zurück zum Zitat Tsujikawa A, Sakamoto A, Ota M et al (2010) Serous retinal detachment associated with retinal vein occlusion. Am J Ophthalmol 149:291–301 e295PubMedCrossRef Tsujikawa A, Sakamoto A, Ota M et al (2010) Serous retinal detachment associated with retinal vein occlusion. Am J Ophthalmol 149:291–301 e295PubMedCrossRef
27.
Zurück zum Zitat Noma H, Funatsu H, Shimada K, Mimura T (2013) Influence of pars plana vitrectomy on macular sensitivity and morphology in patients with branch retinal vein occlusion and serous retinal detachment. Ophthalmic Surg Lasers Imaging Retina 44:160–167PubMedCrossRef Noma H, Funatsu H, Shimada K, Mimura T (2013) Influence of pars plana vitrectomy on macular sensitivity and morphology in patients with branch retinal vein occlusion and serous retinal detachment. Ophthalmic Surg Lasers Imaging Retina 44:160–167PubMedCrossRef
Metadaten
Titel
Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion
verfasst von
Hidetaka Noma
Katsunori Shimada
Tatsuya Mimura
Publikationsdatum
01.12.2013
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 6/2013
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-013-9762-2

Weitere Artikel der Ausgabe 6/2013

International Ophthalmology 6/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.